FDA Draft Guidance Seeks Comments on Drug Platform Tech Designation

The FDA’s draft guidance on platform technology designations for drug development outlines how sponsors can submit a designation request and the benefits of the designation.
Source: Drug Industry Daily

Leave a Reply